Tanespimycin in Treating Patients With Stage III-IV Melanoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well tanespimycin works in treating patients with stage
III or stage IV melanoma. Antitumor antibiotics such as tanespimycin may stop the growth of
melanoma by stopping blood flow to the tumor.